Pub Date : 1900-01-01DOI: 10.52556/2587-3873.2021.1(88).09
Artur Colța, Vitalie Ghicavîi
This study presents the importance of entomotherapy in chronic non bacterial prostatitis. Administration of combine therapy with adenoprosine at the patients with various forms of non bacterial CP (inflammatory and non-inflammatory), demonstrate antioxidant and anti-inflammatory action, in combination with modern complementary methods, signifi cantly increases the effectiveness of treatment, improves patients’ quality of life and optimizes duration of treatment – treatment can be reduced from 3 months to 30 days. According to the results of the study, of all patients investigated with chronic non bacterial prostatitis, with or without symptoms of urinary disorders, only 27 (82%) of patients did not detect another condition, responsible for the above-mentioned disorders.
{"title":"Entomotherapy in chronic nonbacterial prostatitis","authors":"Artur Colța, Vitalie Ghicavîi","doi":"10.52556/2587-3873.2021.1(88).09","DOIUrl":"https://doi.org/10.52556/2587-3873.2021.1(88).09","url":null,"abstract":"This study presents the importance of entomotherapy in chronic non bacterial prostatitis. Administration of combine therapy with adenoprosine at the patients with various forms of non bacterial CP (inflammatory and non-inflammatory), demonstrate antioxidant and anti-inflammatory action, in combination with modern complementary methods, signifi cantly increases the effectiveness of treatment, improves patients’ quality of life and optimizes duration of treatment – treatment can be reduced from 3 months to 30 days. According to the results of the study, of all patients investigated with chronic non bacterial prostatitis, with or without symptoms of urinary disorders, only 27 (82%) of patients did not detect another condition, responsible for the above-mentioned disorders.","PeriodicalId":269453,"journal":{"name":"Public Health, Economy and Management in Medicine","volume":"32 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"115022711","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 1900-01-01DOI: 10.52556/2587-3873.2021.1(88).07
S. Buruiana
Oncological disease is a hypercoagulable state with an associated increased risk of venous thromboembolism and is associated with high rates of recurrence and mortality. For those reasons, the prevention of cancer-associated thrombosis is of paramount importance. Knowledge of thromboembolic risk factors in oncology is absolutely necessary for the evaluation of the individual risk-benefit ratio of prophylaxis. The aim of this paper is to elucidate the risk factors of thromboembolic complications in cancer patients. In order to achieve the set aim, the medical scientifi c publications from the GoogleSearch database, PubMed, Z-library, NCIB, Medscape, Hinari, were searched for the keywords: „cancer-associated thrombosis”, „cancer”, „risk factor”. The information was systematized, highlighting the risk factors for thromboembolic complications in patients with cancer.
{"title":"Management of the risk of thromboembolic complications in oncology","authors":"S. Buruiana","doi":"10.52556/2587-3873.2021.1(88).07","DOIUrl":"https://doi.org/10.52556/2587-3873.2021.1(88).07","url":null,"abstract":"Oncological disease is a hypercoagulable state with an associated increased risk of venous thromboembolism and is associated with high rates of recurrence and mortality. For those reasons, the prevention of cancer-associated thrombosis is of paramount importance. Knowledge of thromboembolic risk factors in oncology is absolutely necessary for the evaluation of the individual risk-benefit ratio of prophylaxis. The aim of this paper is to elucidate the risk factors of thromboembolic complications in cancer patients. In order to achieve the set aim, the medical scientifi c publications from the GoogleSearch database, PubMed, Z-library, NCIB, Medscape, Hinari, were searched for the keywords: „cancer-associated thrombosis”, „cancer”, „risk factor”. The information was systematized, highlighting the risk factors for thromboembolic complications in patients with cancer.","PeriodicalId":269453,"journal":{"name":"Public Health, Economy and Management in Medicine","volume":"26 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"116795627","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 1900-01-01DOI: 10.52556/2587-3873.2021.1(88).05
Victor Ghicavii, T. Chiriac
The contemporary doctor has an enormous number of drugs for the prophylaxis and treatment of various ailments. Qualitative drug treatment is due to the determination of key moments in the evolution of the disease in the specifi c patient (individual), followed by a correct prescription of the drug, eff ective selection or substitution and rational use of drugs compliance with the requirements and recommendations of protocols and clinical standards. adherence to treatment regimens, at the same time the exclusion of undue arguments (polypragmatism, polytherapy) and prevention of possible adverse adverse events (incompatibilities), timely detection with prevention of use of counterfeit drugs and fi nally revocation of all irrational challenges and consequences Treating Th e apparent economy of means of improper substitution of original preparations with generics can lead to an increase in the frequency of adverse eff ects and a reduction in the quality of life of patients, as well as lead to a considerable increase in costs. Th e reckless transition from the original to the generic preparation can have unpredictable consequences for the patient.
{"title":"Efficient and qualitative medicinal treatment – consequence of rational selection and use of medicines","authors":"Victor Ghicavii, T. Chiriac","doi":"10.52556/2587-3873.2021.1(88).05","DOIUrl":"https://doi.org/10.52556/2587-3873.2021.1(88).05","url":null,"abstract":"The contemporary doctor has an enormous number of drugs for the prophylaxis and treatment of various ailments. Qualitative drug treatment is due to the determination of key moments in the evolution of the disease in the specifi c patient (individual), followed by a correct prescription of the drug, eff ective selection or substitution and rational use of drugs compliance with the requirements and recommendations of protocols and clinical standards. adherence to treatment regimens, at the same time the exclusion of undue arguments (polypragmatism, polytherapy) and prevention of possible adverse adverse events (incompatibilities), timely detection with prevention of use of counterfeit drugs and fi nally revocation of all irrational challenges and consequences Treating Th e apparent economy of means of improper substitution of original preparations with generics can lead to an increase in the frequency of adverse eff ects and a reduction in the quality of life of patients, as well as lead to a considerable increase in costs. Th e reckless transition from the original to the generic preparation can have unpredictable consequences for the patient.","PeriodicalId":269453,"journal":{"name":"Public Health, Economy and Management in Medicine","volume":"1 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"129083832","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 1900-01-01DOI: 10.52556/2587-3873.2021.1(88).08
Tatiana Malacinschi-Codreanu
Cost-effectiveness analysis (CEA) is a tool for selecting an alternative solution to achieve the same quantifi ed objective in physical units of measurement. CEA provides the analytical framework for identifying the most effective tactics for using limited resources. The analysis of the data from the specialized literature, allowed to determine the degree of implementation of the cost-eff ectiveness analysis in the public health system both at international and national level, and its practical application in clinical medicine. The origin of the CEA comes from the military service, where it was first requested to identify the most rational way to use financial resources to achieve the proposed objectives, being subsequently applied in various social fi elds, including the health system, stipulating data on technology, principles of application of the CEA. The need to evaluate the profi tability of surgical interventions is determined by the progressive increase of the costs of the medical services offered, by the appearance of alternative methods of treatment of a pathology, the limitation of the fi nancing of highly specialized technologies. Economic evaluation of the effectiveness of treatment in the acute abdomen is an important goal of clinical medicine. CEA evaluation is a tool for argumentation and promotion laparoscopic methods in the diagnosis and treatment of acute abdomen, compared to traditional classical methods.
{"title":"Evaluating the cost-effectiveness of laparoscopy in the acute abdomen","authors":"Tatiana Malacinschi-Codreanu","doi":"10.52556/2587-3873.2021.1(88).08","DOIUrl":"https://doi.org/10.52556/2587-3873.2021.1(88).08","url":null,"abstract":"Cost-effectiveness analysis (CEA) is a tool for selecting an alternative solution to achieve the same quantifi ed objective in physical units of measurement. CEA provides the analytical framework for identifying the most effective tactics for using limited resources. The analysis of the data from the specialized literature, allowed to determine the degree of implementation of the cost-eff ectiveness analysis in the public health system both at international and national level, and its practical application in clinical medicine. The origin of the CEA comes from the military service, where it was first requested to identify the most rational way to use financial resources to achieve the proposed objectives, being subsequently applied in various social fi elds, including the health system, stipulating data on technology, principles of application of the CEA. The need to evaluate the profi tability of surgical interventions is determined by the progressive increase of the costs of the medical services offered, by the appearance of alternative methods of treatment of a pathology, the limitation of the fi nancing of highly specialized technologies. Economic evaluation of the effectiveness of treatment in the acute abdomen is an important goal of clinical medicine. CEA evaluation is a tool for argumentation and promotion laparoscopic methods in the diagnosis and treatment of acute abdomen, compared to traditional classical methods.","PeriodicalId":269453,"journal":{"name":"Public Health, Economy and Management in Medicine","volume":"22 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"115137379","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 1900-01-01DOI: 10.52556/2587-3873.2021.1(88).10
Alexei Pleșacov, Ion Vladanov, Artur Colța, Vitalie Ghicavîi
Laser prostate surgery is currently considered as being an alternative to other surgical approaches like mono or bipolar transurethral resection and classical open surgery. The implementation of transurethral Thulium: YAG laser vapoenucleation of the prostate opens up new avenues in the treatment of benign prostatic hyperplasia. Therefore, the use of Th uVEP and the subsequent fragmentation of vapoenucleated adenomatous nodules may completely change the surgical approach in the treatment of benign prostatic hyperplasia. The study included 23 patients with benign prostatic hyperplasia, who underwent minim invasive surgical treatment via transurethral Thulium: YAG laser vapoenucleation within the Urology Clinic of „Nicolae Testemitanu” SUMPh. The patients tolerated the surgical procedure well. Patients, with mean age of 62.4±3 years, were assessed at 3, 6, and 12 months aft er the surgery. A constant improvement of the IPSS and QoL scores was determined. A 15-point IPSS and 2-point Qol decrease was registered. No signifi cant decrease in IIFE-5 score was reported. The highest Qmax and Qmean increase was registered at 12 months: 150% and 139.4% respectively. The mean urine output increased to 59ml or 47.9%. The mean prostate volume decreased to 41±5cm3 (-4.1%), whereas the volume of residual urine showed a decrease of about 66±18ml (-77%). Given the excellent effi cacy of minimally invasive ThuVEP, it might be recommended as a surgical method of choice in the treatment of benign prostatic hyperplasia.
{"title":"Transurethral Thulium: YAG laser vapoenucleation of the prostate","authors":"Alexei Pleșacov, Ion Vladanov, Artur Colța, Vitalie Ghicavîi","doi":"10.52556/2587-3873.2021.1(88).10","DOIUrl":"https://doi.org/10.52556/2587-3873.2021.1(88).10","url":null,"abstract":"Laser prostate surgery is currently considered as being an alternative to other surgical approaches like mono or bipolar transurethral resection and classical open surgery. The implementation of transurethral Thulium: YAG laser vapoenucleation of the prostate opens up new avenues in the treatment of benign prostatic hyperplasia. Therefore, the use of Th uVEP and the subsequent fragmentation of vapoenucleated adenomatous nodules may completely change the surgical approach in the treatment of benign prostatic hyperplasia. The study included 23 patients with benign prostatic hyperplasia, who underwent minim invasive surgical treatment via transurethral Thulium: YAG laser vapoenucleation within the Urology Clinic of „Nicolae Testemitanu” SUMPh. The patients tolerated the surgical procedure well. Patients, with mean age of 62.4±3 years, were assessed at 3, 6, and 12 months aft er the surgery. A constant improvement of the IPSS and QoL scores was determined. A 15-point IPSS and 2-point Qol decrease was registered. No signifi cant decrease in IIFE-5 score was reported. The highest Qmax and Qmean increase was registered at 12 months: 150% and 139.4% respectively. The mean urine output increased to 59ml or 47.9%. The mean prostate volume decreased to 41±5cm3 (-4.1%), whereas the volume of residual urine showed a decrease of about 66±18ml (-77%). Given the excellent effi cacy of minimally invasive ThuVEP, it might be recommended as a surgical method of choice in the treatment of benign prostatic hyperplasia.","PeriodicalId":269453,"journal":{"name":"Public Health, Economy and Management in Medicine","volume":"104 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"124631001","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 1900-01-01DOI: 10.52556/2587-3873.2021.1(88).11
Gheorghii Țurcanu, E. Dupouy, I. Bahnarel
Very little is currently known about the consumption of different fish species at the national level. Elucidation of this subject would be useful for assessing the risk of exposure of the population to methyl mercury, polychlorinated biphenyls, dioxins and assessing nutritional benefi ts such as protein, amino acids, fats, vitamins, minerals, phosphorus, iodine intake. This is a descriptive study, with the application of the indirect method of data collection. The identifi cation of fi sh species and the quantifi cation of consumption at national level was performed using FishStatJ v4.00.9 soft ware. Data per species (annual series) for the period 2005-2017, tons per year, were converted into grams per day per capita. The inedible component was excluded by applying conversion factors. During the analyzed period, 26 species of fish were consumed. The application of conversion factors decreased the average consumption by 34.7% in relation to gross amount. In the period 2005-2017 there was a trend of increasing fish consumption from 17.8 g/day (2005) to 23.6 g/day (2017). On average per capita was consumed 19.68 g/day, 97.3% out of the average consumption are: herring/sardines – 6.46 g/day (32.8%), carp – 4.14 g/day (21.0%), unspecifi ed species – 3.09 g/day (15.7%), mackerel – 1.61 g/day (8.17%), hake – 1.10 g/day (5.6%), putasu – 0.953 g/day (4.84%), salmon – 0.824 g/day (4.19%), cod – 0.745 g/day (3.78%), polack – 0.22 g/ day (1.14%), tuna – 0.09 g/day (0.47%). Fish consumption for the period 2005-2017 has a continuous growth trend. The population of the Republic of Moldova consumes 26 diff erent fi sh species, the most consumed are herring/sardines and carp with a share of 32.8% and 21.0% respectively. However, 15.7% remains uncertain due to non-identifi cation of species.
{"title":"Fish consumption among the population of the Republic of Moldova","authors":"Gheorghii Țurcanu, E. Dupouy, I. Bahnarel","doi":"10.52556/2587-3873.2021.1(88).11","DOIUrl":"https://doi.org/10.52556/2587-3873.2021.1(88).11","url":null,"abstract":"Very little is currently known about the consumption of different fish species at the national level. Elucidation of this subject would be useful for assessing the risk of exposure of the population to methyl mercury, polychlorinated biphenyls, dioxins and assessing nutritional benefi ts such as protein, amino acids, fats, vitamins, minerals, phosphorus, iodine intake. This is a descriptive study, with the application of the indirect method of data collection. The identifi cation of fi sh species and the quantifi cation of consumption at national level was performed using FishStatJ v4.00.9 soft ware. Data per species (annual series) for the period 2005-2017, tons per year, were converted into grams per day per capita. The inedible component was excluded by applying conversion factors. During the analyzed period, 26 species of fish were consumed. The application of conversion factors decreased the average consumption by 34.7% in relation to gross amount. In the period 2005-2017 there was a trend of increasing fish consumption from 17.8 g/day (2005) to 23.6 g/day (2017). On average per capita was consumed 19.68 g/day, 97.3% out of the average consumption are: herring/sardines – 6.46 g/day (32.8%), carp – 4.14 g/day (21.0%), unspecifi ed species – 3.09 g/day (15.7%), mackerel – 1.61 g/day (8.17%), hake – 1.10 g/day (5.6%), putasu – 0.953 g/day (4.84%), salmon – 0.824 g/day (4.19%), cod – 0.745 g/day (3.78%), polack – 0.22 g/ day (1.14%), tuna – 0.09 g/day (0.47%). Fish consumption for the period 2005-2017 has a continuous growth trend. The population of the Republic of Moldova consumes 26 diff erent fi sh species, the most consumed are herring/sardines and carp with a share of 32.8% and 21.0% respectively. However, 15.7% remains uncertain due to non-identifi cation of species.","PeriodicalId":269453,"journal":{"name":"Public Health, Economy and Management in Medicine","volume":"37 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"116301256","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：